Discovering the Miracle of Stem Cells

Education—Basuki Supartono was born in Jakarta. He completed his secondary education at SMA Negeri 8 Jakarta (1980), earned his Bachelor's degree in Psychology from UI (1983), graduated as a General Practitioner from FK Unair (1989), specialized in Orthopedics and Trauma at FK UI (2000), obtained a Master's in Hospital Administration from FKM UI (2006), and earned his Doctorate from FK UI (2013) with honors as the best PhD graduate. Career in Civil Service—Since 1990, he has held the rank of Senior Doctor (IVe)/Principal. He also served as the Expert Staff to the Minister of Youth and Sports of the Republic of Indonesia and as the Director of the National Sports Hospital (RSON). Academic Responsibilities—His expertise is in the musculoskeletal field. He has served as the Vice Dean II of the Faculty of Medicine at UPN Veteran Jakarta and currently chairs the Senate of the same university. He teaches undergraduate and master degrees program at UPN Veteran Jakarta, master degree program at UI and ITB, and PhD program at UI. He actively conducts research and publishes scientific papers. He serves as a reviewer for the Heliyon Journal, the Wijaya Kusuma Scientific Journal, and an editor for the IRCHum Journal and BRIN Publishing (this book). He is a member of IDI, PABOI, ISAKOS, and the Health Research Ethics Committee. Awards—Satya Lencana Karya Satya XX. Satya Lencana Kebaktian Sosial for Disaster Relief Efforts during the Tsunami in NAD/North Sumatra Province from the President of the Republic of Indonesia. Humanitarian Award for Health Services in Maluku and North Maluku Provinces from the Minister of Health of the Republic of Indonesia. Recognition from the Minister of Youth and Sports of the Republic of Indonesia for his dedication, service, and achievements as the Director of RSON and in the development of RSON. Satya Lencana Karya Satya XXX. Scientific Awards—The Best Poster at the 20th National Congress of Indonesian Orthopaedic Association, Jakarta 2016. The 3rd Winner for Oral Presentation in National Symposium and Workshop Stem Cell for The Future Medicine from Basic to Clinic, Surabaya 2017.

Ariyani Noviantari is a researcher at The Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN) since March 2022. Between March 2010 and February 2022, she worked as a researcher at the Center for Research and Development of Biomedical and Basic Health Technology, Health Policy Agency (Badan Kebijakan Pembangunan Kesehatan—BKPK), Ministry of Health, previously known as National Institute of Health Research and Development (Balitbangkes), Ministry of Health of Indonesia. Before this, she worked as a Microbiologist in PT. Universal Robina Corporation (URC) Indonesia (Jack ‘n Jill) (2005–2007) and GlaxoSmithKline Indonesia (2007–2010). The author is identified by her Scopus ID 57208311735, Orcid ID 0000-0001-7852-6983, and Sinta ID 6630099. She finished her undergraduate studies with cum laude predicate at the Faculty of Biology, Universitas Gadjah Mada (UGM). She then pursued her master's degree at the Master Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia. She is currently obtaining a doctorate at the Doctoral Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia.
Noviantari is a member of Perhimpunan Periset Indonesia, formerly known as the Himpunan Peneliti Indonesia (Himpenindo), the Indonesian Medical Biology Association (Perkumpulan Biologi Medik Indonesia—PBMI), and worked as the Editorial Board of the Indonesian Biotech Medisiana Journal (Jurnal Biotek Medisiana Indonesia—JBMI) (2018–2022). She received the award for Best Moderated Poster at the 4th Annual International Conference and Exhibition on Indonesian Medical Education and Research Institute (ICE on IMERI) in 2019 and Satyalancana Karya Satya 10 years award. Additionally, she received the award as The Best and Most Productive Writer from Widina Media Utama Publishers. She has published books and articles in various national and international scientific publications and proceedings.

Ahmad Faried currently works as the head of the study program at the Department of Neurosurgery and Oncology and Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung, Indonesia. He completed his PhD in Medicine at Gunma University, Maebashi, Japan, under the supervision of Prof. Hiroyuki Kuwano and Prof. Hiroyuki Kato. He received his post-doctoral grant from JSPS Japan at the same university. He continued his clinical fellowship in Department of Neurosurgery at the University of Tokyo, Japan, under the supervision of Prof. Nobuhito Saito and Prof. Hideaki Imai.
He is a neurosurgeon with cell biology as his expertise. He has a great deal of interest in neuroscience research such as neurotrauma, brain tumour malignancy, brain microvessel endothelial cells, placenta stem cells, neural stem cells, iPSC, cancer stem cells, neurosurgery, biomedical engineering, and the medical information communication and technology (ICT); especially instrumentation as well as telemedicine and integrated medical services using cloud computing system.
He received many awards in both professional and academic and industry. Among them are Innovation Award II-2018 from Indonesian Health Care Forum, Jakarta; the Young Neurosurgeon Award 2017 from the World Federation of Neurosurgical Societies in the World Congress 2017, Istanbul, Turkey; The National Outstanding Lecturer and Education Personnel Year 2012 from the Indonesian Ministry of Higher Education, Research Technology; and Ristek-Kalbe Science Award 2010 from Kalbe Pharmaceutical Company supported by Indonesian Ministry Research and Technology. He is a member of the Indonesian Young Academy of Sciences (Akademi Ilmuan Muda Indonesia, ALMI)
Ahmad Faried is also a key participant in the Konsorsium Pengembangan Sel Punca and serves on the Adhoc Team for Health Minister Regulations (Tim Adhoc Peraturan Menteri Kesehatan–Permenkes). He is actively involved in The Indonesian Association of Tissue Engineering and Cell Therapy (REJASELINDO) and contributes his expertise to the organization, specializing in application of stem cell therapy. Additionally, he also a Board Certified and as a member of the American Board of Regenerative Medicine (ABRM) and Head of Sub-Commission II, National Committee for Stem Cell and Cell Development, Ministry of Health of The Republic of Indonesia.

Dr. Aisha Aziz is an assistant Professor, Pharmacology, Faculty of Pharmacy, Jinnah University for Women. She received her PhD in Pharmacology in 2019. Her research was on the in vitro screening of acetamide and benzimidazole derivatives on breast cancer cell lines. She has been trained in various in vitro and in vivo research techniques. Her research experience includes in vitro screening of novel drugs and nanoparticles on cancer cell lines, such as breast cancer, glioblastoma, and lung cancer cell lines. Aisha Aziz has been supervising more than 10 MPhil students and is currently working on in vivo and in vitro models of neurodegenerative diseases, inflammation, and drug-induced toxicity.

Angliana pursued her doctoral studies at the Faculty of Pharmacy, Universitas Padjajaran. Her groundbreaking dissertation, Effect of Mesenchymal Stem Cell-Derived Conditioned Medium Co-cultured with Mononuclear Cell from Type 2 Diabetes Mellitus Patient on Insulin Resistance Model HepG2 Cell, exemplifies her commitment to advancing scientific knowledge. Angliana currently applies her expertise as the Quality and Development Supervisor at Prodia StemCell Indonesia.

Atikah Anwar Hasibuan earned her bachelor's degree in biology from Universitas Indonesia. She currently serves as the Advisor for Stem Cell Therapy at PT. Prodia StemCell Indonesia, focusing on internal and skin diseases. In addition to her advisory role, she has responsibilities related to toll manufacturing. Several of her writings have been published in Cytotherapy, the official jou

Aw Tar Choon is an expert in the field of medicine and clinical chemistry. He completed his medical education at the University of Malaya Medical School, followed by a master's degree in public policy at Harvard-NUS. He underwent training in Internal Medicine at Singapore General Hospital and King's College Hospital & Medical School. Additionally, he pursued training in clinical chemistry at the Department of Pathology & Laboratory Medicine at the Hospital of the University of Pennsylvania. Aw Tar Choon is the Director of Chemical Pathology at the Department of Laboratory Medicine at Changi General Hospital and the Head of Biochemistry Service at Seng Kang Hospital. Despite his busy schedule, he holds academic appointments as a Clinical Senior Lecturer (Medicine) at the National University of Singapore (NUS) and Clinical Professor (Pathology) at Duke-NUS Graduate Medical School. He was elected as Fellow of the Royal College of Physicians of Edinburgh (1999), Fellow of the Chapter of Pathologists Academy of Medicine Singapore (2004), and International Fellow College of American Pathologists (2020). His professional qualifications include a Board Certification in Internal Medicine from NUS and The Royal College of Physicians (UK), as well as a Sub-specialty Board Certification in Chemical Pathology from the Royal College of Pathologists of Australasia. He is a member of the Royal College of Physicians in Edinburgh and Ireland and The Academy of Medicine Singapore.
Additionally, he is on the Executive Council of several global scientific institutions, including the Singapore Association of Clinical Biochemists, the Singapore Society of Pathology, and The Endocrine & Metabolic Society of Singapore. He has published over 200 journal articles, including 17 on Covid-19, and delivered over 370 lectures in 25 countries, including 11 webinars on Covid-19. He is a recipient of several distinguished national and international awards. He also serves on the editorial boards of several journals, including Nature Scientific Reports.

Bayu Winata Putera completed his bachelor's degree in pharmacy, followed by a pharmacist profession at Universitas Padjajaran. He pursued his postgraduate education at Hasanuddin University, focusing on Biomedics, specifically a concentration in Clinical Chemistry. His research focused on the role of visfatin obestatin in the proliferation of pancreatic beta cells and was published in the Indonesian Biomedical Journal. He pursued his doctoral studies at the Faculty of Medicine, Hasanuddin University. His dissertation, Stem Cell Dynamics in Stroke Patients who have undergone Intra-Arterial Heparia Flushing explores Hematopoietic Stem Cells (HSC), Mesenchymal Stem Cells (MSC), Endothelial Progenitor Cells (EPC), and Very Small Embryonic Like Cells (VSEL). Bayu Winata Putera currently serves as the Operational Manager at Prodia StemCell Indonesia.

Billy Yosua Costantin Pongajow graduated with a bachelor's degree in biotechnology from the University of Pelita Harapan. In 2023, he garnered recognition through the Student Creativity Program-Scientific Article, showcasing his commitment to academic excellence. Additionally, Billy brings practical experience to the table, having served as an intern in the Research-Based Therapy Department at Prodia StemCell Indonesia in 2022.

Cita Rosita Sigit Prakoeswa is the Director of Dr. Soetomo General Hospital in Surabaya, Indonesia. She earned her Doctorate from Universitas Airlangga in 2007 and was inaugurated as a Professor at Universitas Airlangga in 2019. Her expertise is in dermatology and venereology.

Cosphiadi Irawan, a distinguished medical professional, completed his medical education at Universitas Indonesia. He further pursued specialized training in internal medicine through the Internal Medicine Specialist Education Program at the same institution. In 2011, he achieved a subspecialist designation in Internal Medicine, demonstrating his commitment to excellence in his field. In 2015, Cosphiadi Irawan earned a doctorate from the Universitas Indonesia, solidifying his academic prowess and dedication to advancing medical knowledge. Currently serving as a Clinical Educator at the Faculty of Medicine, Internal Medicine Study Program, he holds the esteemed position of Lector. Cosphiadi Irawan’s expertise lies in the realm of Hematology-Oncology, where he contributes significantly as a staff member in the Hematology-Oncology Division within the Department of Internal Medicine at the Faculty of Medicine, Universitas Indonesia, and Dr. Cipto Mangunkusumo National General Hospital (FKUI/RSCM). His professional journey reflects a remarkable commitment to education and clinical excellence.

Cynthia Retna Sartika completed her doctoral degree in the Faculty of Medicine at Universitas Hasanuddin in 2009. She has engaged in a multifaceted and distinguished career and is also actively involved in various professional organizations and committees, which contribute significantly to the fields of atherosclerosis and vascular diseases. Her notable affiliations include memberships in the Persatuan Atherosclerosis dan Penyakit Vascular Indonesia (PAPVI), the International Society of Stem Cell Research (ISCCR), the International Society of Cell & Gene Therapy (ISCT), and the International Society of Extracellular Vesicles (ISEV). Cynthia Retna Sartika is also a key participant in the Konsorsium Pengembangan Sel Punca and serves on the Adhoc Team for Health Minister Regulations (Tim Adhoc Peraturan Menteri Kesehatan–Permenkes). Additionally, she is also actively involved in the Asosiasi Sel Punca Indonesia (ASPI) or Indonesia Stem Cell Association and contributes her expertise to the team, specializing in the Good Manufacturing Practice for Pharmaceuticals (Tim Ahli Cara Pembuatan Obat yang Baik–CPOB). As a member of the Asian Cellular Therapy Organization (ACTO) and the Research and Networking Commission at the Committee for Stem Cell and Cell Development, Ministry of Health of the Republic of Indonesia, Cynthia Retna Sartika demonstrates a strong commitment to advancing scientific research and healthcare practices in Indonesia.

David Victorious Lukas is a general practitioner who completed his training at the Faculty of Medicine of Universitas Pelita Harapan, Indonesia. He is now pursuing his Master’s in Nutrition and Population Health at Deakin University, Australia. He has various interests and has helped in several other teams, from internal medicine to telehealth. He is committed to providing holistic quality care, particularly in terms of prevention through lifestyle and nutrition.

Dewi Wulandari earned her doctoral degree from the Universitas Indonesia in 2022. Currently, she serves in the Department of Clinical Pathology at the Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital (FKUI/RSCM). She holds the position of Doctor in Charge at Prodia Stemcell Indonesia (ProSTEM).

Dito Anurogo is currently earning his PhD at IPCTRM College of Medicine Taipei Medical University, Taiwan, that will be finished in December 2024. His expertise is study on stem cells, regenerative medicine, molecular medicine, immunology, neuroscience, nanotechnology, nanoimmunobiotechnomedicine, medicine, health, and herbs. Dito Anurogo’s focus research is on Nanoimmunobiotechnomedicine 5.0.

Ditta Kalyani Devi achieved her master's degree at Universitas Padjajaran with a research focus on the effect of UC-MSC and CM UC-MSC administration on IL, MMP, and COMP levels in osteoarthritis SF-MSC. Currently, she serves as the Marketing Therapy Supervisor at Prodia StemCell Indonesia. Her academic dedication and research experience uniquely position her in a crucial capacity within the organization, overseeing marketing strategies related to therapy.

Eka Ginanjar earned his doctorate from the Universitas Indonesia in 2019. With extensive experience as a clinician and academician, Ginanjar has made significant contributions as the Head of the Integrated Heart Service (Pelayanan Jantung Terpadu–PJT) at Dr. Cipto Mangunkusumo National General Hospital (RSCM) from 2014 to 2023. Serving as a Specialist in Internal Medicine and Consultant Cardiologist at the same institution, he honed his skills through an Interventional and Clinical Cardiology Fellowship Training Program at the National Heart Institute of Malaysia in 2012. His outstanding expertise is recognized through fellowships at leading organizations, such as the Indonesian Society of Internal Medicine (FINASIM), the American College of Physicians (FACP), and the International College of Angiology (FICA). Actively engaged in professional associations, such as PAPDI (Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia/Indonesian Society of Internal Medicine) and IKKI (Ikatan Keseminatan Kardioserebrovaskular Indonesia/Indonesian Cardiocerebrovascular Society), Eka Ginanjar demonstrates his dedication to advancing cardiovascular care in Indonesia.

Elizabeth Merry Wintery is a specialist in Internal Medicine who provides various medical services, such as Internal Medicine Consultation and Immunology Consultation. One of her practice locations is Medistra Hospital in Jakarta. She completed her specialization degree in Internal Medicine at the Universitas Indonesia. She is registered as a member of the Indonesian Association of Specialists in Internal Medicine.

Idrus Alwi is a distinguished Cardiology Consultant at the Universitas Indonesia and is recognized for his exceptional expertise and significant contributions to the field of interventional cardiology and stem cell research. Idrus Alwi embarked on his academic journey at Universitas Indonesia, graduating as a specialist in internal medicine in 1996 and as a cardiology consultant in 2001. His passion for advancing medical knowledge led him to pursue a PhD at the same institution, which he completed in 2006. In 2012, with an unwavering commitment to academic excellence and patient care, Idrus Alwi was appointed as a professor of Internal Medicine at Universitas Indonesia, a position he continues to hold with dedication and distinction. Throughout his illustrious career, Idrus Alwi has demonstrated a profound dedication to advancing the field of interventional cardiology and stem cell applications, pioneering novel techniques and methodologies that have been instrumental in exploring innovative treatment modalities.

Ika Prasetya Wijaya completed his medical education at Universitas Indonesia in 1992. He then continued his specialist education in internal medicine at the Specialist Doctor Education Program at Universitas Indonesia and graduated in 2003. In 2011, Ika Prasetya Wijaya completed his subspecialist education in Internal Medicine at the same university. Now, he serves as a clinical educator at the Faculty of Medicine, Internal Medicine Study Program at Universitas Indonesia, where his current functional position is as a lector. He is an expert in the field of cardiology. He is listed as a member of the staff of the Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital (FKUI/RSCM). He is a member of the Greater Jakarta Branch of the Indonesian Society of Internal Medicine (PAPDI).

Jeanne Adiwinata Pawitan earned her docotrate at Faculty of Pharmaceutical Sciences, Osaka University. Her current affiliation is Faculty of Medicine, Universitas Indonesia. Jeanne’s expertise is on histology, stem cells, and tissue engineering.

Jennifer Lheman is a senior researcher at Tarumanagara Human Cell Technology (THCT) Laboratory, Jakarta, Indonesia. She completed her Master's Degree at Atma Jaya Catholic University, Jakarta, Indonesia, in 2019. She is currently the deputy head of the THCT Laboratory and has published more than five papers in international journals. She specializes in tissue engineering and biomaterials development. Along with Dr. Siufui and the THCT team, she has conducted numerous laboratory trials and several animal studies. Her research works currently focus on developing secretomes derived from mesenchymal stem cells and their therapeutic applications, especially for diabetic treatment, liver cirrhosis, and hernia repair.

Marsya Nilam Kirana holds a Master of Science in Stem Cell Engineering for Regenerative Medicine from the University of Glasgow. With expertise in stem cell research and biomaterials, her background aligns well with her previous role as a scientist and advisor for stem cell therapy at PT. Prodia StemCell Indonesia. Marsya actively contributes to scientific discourse and innovation in her areas of specialization.

Mochamad Syaifudin was born in the small town of Lamongan on August 16, 1963. He completed his Medical doctorate at Universitas Airlangga in 1990. He pursued his Master's degree in Hospital Admissions at Airlangga University, graduated in 2000. In 2015, he earned a Master of Biomedical Science degree at Udayana University. He then pursued his education at the Doctoral Medical Science Study Program, focusing on bone marrow transplantation in thalassemia major at Universitas Udayana, Bali. He is a doctor and director of the Clinic Regenerative Medicine MMC Lamongan. In 2012, he completed his Master of Biomedical Sciences, and by 2021, he had completed a doctoral program in stem cell applications for degenerative diseases. He began developing a service of excellence at the Regenerative Medicine Clinic under the name of Cell Rejuvenation Therapy (Terapi Peremajaan Sel), focusing on facial rejuvenation, hair growth, and degenerative diseases such as diabetes mellitus.

Mohamad Syahrir Azizi completed his education at the University of Indonesia in 2019. He has established a noteworthy presence in the field of cardiovascular imaging. As a dedicated member of the Asian Pacific Society of Cardiovascular Imaging (ASCI), he actively contributes to advancing knowledge and practices in cardiovascular health. Additionally, he holds membership in the American Society of Echocardiography (ASE), reflecting his commitment to staying at the forefront of international developments in cardiovascular imaging. He has been honored with a fellowship in the International College of Angiology (ICA), denoted by the prestigious title FICA. Further showcasing his recognition within the medical community, Mohamad Syahrir Azizi holds fellowships in PAPDI (Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia/Indonesian Society of Internal Medicine) and FINASIM (Fellowship of Indonesian Society of Internal Medicine). He is also an esteemed member of IDI (Ikatan Dokter Indonesia/Indonesian Medical Association) and actively participates in the IKKI (Ikatan Keseminatan Kardioserebrovaskular Indonesia/ Indonesian Cardiocerebrovascular Society), emphasizing his dedication to the advancement of cardiovascular care and expertise in Indonesia.

Nabilla Farah Naura is a Master of Science student at University College London studying the Manufacture and Commercialization of Stem Cell and Gene Therapies. She received a full-ride scholarship for her Master's study from the Indonesia Endowment Funds for Education (LPDP), Ministry of Finance. Previously, she was an Advisor for Stem Cell Therapy at PT. Prodia Stem Cell Indonesia for 2,5 years managing stem cell clinical trials and scientific publications. Several of her writings have been published in Cytotherapy, the official journal of the International Society of Cell and Gene Therapy (ISCT).

Nadya Karina completed her Biotechnology studies at Al Azhar University in 2017. She has been working for four years in the field of stem cells as an Advisor for stem cell therapy, mainly focusing on stem cells in the areas of the heart and neurology.

Rima Haifa completed her bachelor's degree in biology at Universitas Indonesia. She pursued her master’s degree at Universitas Padjadjaran, focusing on Pharmacy, specifically a concentration in Clinical Pharmacy. Her thesis focused on the role of dendritic cells derived from autologous peripheral blood or allogeneic umbilical cord blood in T cells of nasopharyngeal carcinoma patients. She is an esteemed member of various professional associations, including the Asosiasi Sel Punca Indonesia (ASPI/Indonesian Stem Cell Association), the International Society of Cell & Gene Therapy (ISCT), the International Society of Extracellular Vesicles (ISEV), and the Asian Cellular Therapy Organization (ACTO). These affiliations underscore her commitment in being abreast of cutting-edge developments in her field. Presently, Rima Haifa holds the position of Research-Based Therapy Supervisor at Prodia StemCell Indonesia.

Saba Majeed is an assistant Professor of Pharmacology, Faculty of Pharmacy, Ziauddin University. She graduated from the field of Pharmacology and Neuroscience from the International Center for Chemical and Biological Sciences, Faculty of Pharmacy, University of Karachi. Her primary interest is neural stem cell research, which aims to modulate neurogenesis to treat neurodegenerative disorders. She has a great passion for exploring novel technologies and therapeutic treatment options to control neurological deficit-related orders; she has worked on neurogenesis and is involved in establishing novel models of co-culturing stem cells and neurons. Her open and contextual evaluation model is based on co-culturing techniques and promotes neurogenesis by exploring new signaling pathways for improving healthcare. She has patented her Ph.D research in neurogenesis for US Patent Isoxylitones mediated neurogenesis. Currently, she works as an assistant professor at Ziauddin University's Department of Pharmacology and is involved in research area of neuroinflammation targeting various signaling mechanisms modulating neurodegenerative diseases like alzhiemer’s, stroke, parkinson’s, etc. She has an excellent command on all molecular and imaging techniques.

Siufui Hendrawan is an Associate Professor at the Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia. She is also the head of Tarumanagara Human Cell Technology (THCT) Laboratory, a research laboratory founded in 2011 in collaboration with Baermed, Switzerland. She completed her PhD at Hassanuddin University, Makassar, Indonesia, in 2017 and has published more than 15 papers in national and international journals. She specializes in tissue engineering, cell biology, and biomaterials science. She has conducted numerous pre-clinical studies and some clinical trials. Her research works specialize in tissue engineering, cell biology, and biomaterials science. She pioneers research focused on the development of mini-organs and cell-matrix implants, as well as the therapeutic application of secretome from mesenchymal stem cells.

Somia Gul is professor at Department of Pharmaceutical Chemistry Faculty of Pharmacy, Jinnah University for Women. She has completed her specialization in Pharmaceutical Chemistry and earned her Ph. D as an HEC Indigenous Ph.D fellowship Scholar from the University of Karachi in 2011. Somia has over 17 Years of teaching, research, and industrial experience as a supervisor of various M. Phil. and Ph.D. research scholars, research projects, and training sections. She has more than 103 research publications in reputed journals with good impact factors and 1 book published.
Her specialization is in medicinal chemistry, and her expertise and research interests mainly focus on drug-drug interactions of different classes of drugs, organic derivative synthesis and metal complexes, natural product chemistry, formulation development, validation and biological evaluation of herbal origin, methods development, and validation for analysis of drugs through HPLC and UV/Vis. Spectroscopy.
Somia’s current research focuses on in-silico drug design, synthesis, biological evaluation, and molecular docking studies of novel analogues of biological interest, especially antimicrobials and anti-tuberculosis agents against resistant pathogens.

Sukmawati Tansil Tan is a dermato­venereology doctor with more than 20 years of experience. She is currently the head of dermatovenereology department at Mayapada Hospital, Tangerang, Indonesia, and an assistant professor at the Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia. She completed her PhD at Hassanuddin University, Makassar, Indonesia in 2012. She is a member of Fellow of The Indonesia Society of Dermatology and Venereology (FinsDV) and Fellow of the Asian Academy of Dermatology and Venerology (FAADV). She has published more than 15 papers in both national and international journals. She is currently focusing on research on the application of secretomes to chronic wounds, especially for diabetic ulcer treatment.

Teguh Santoso is a specialist in internal medicine, especially in cardiovascular, and a cardiology specialist who provides various medical support services, including heart examinations, thoracic, and cardiovascular surgery. One of his practice locations is at Medistra Hospital in Jakarta. He pursued specialized education as a cardiovascular consultant in internal medicine in 1975, and in 1978, he completed his education as a heart and blood vessel specialist. He then continued his Doctor of Philosophy degree at Erasmus Universiteit Rotterdam in 1980. He is registered as a member of the Indonesian Association of Specialists in Internal Medicine and the Indonesian Association of Cardiovascular Specialists.

Winawati Eka Putri is a lecturer at the Faculty of Medicine, Universitas Nahdlatul Ulama Surabaya. She completed her doctoral program at Universitas Airlangga in 2021. She is an expert in Dermatology and Venereology. Her research is currently focusing on the utilization of stem cells in addressing skin problems.

Yanni Dirgantara completed her master’s degree at Universitas Padjajaran with a research focus on mesenchymal stem cells derived secretome comparison between umbilical cord vs adipose tissue. Currently excelling as the Production Laboratory Supervisor at Prodia StemCell Indonesia, she brings her expertise and leadership to the organization. Yanni commits to advancing scientific knowledge, coupled with her adeptness in overseeing production processes within the stem cell laboratory.